MX2010004639A - Formulaciones liquidas de hormona luteinizante (lh). - Google Patents

Formulaciones liquidas de hormona luteinizante (lh).

Info

Publication number
MX2010004639A
MX2010004639A MX2010004639A MX2010004639A MX2010004639A MX 2010004639 A MX2010004639 A MX 2010004639A MX 2010004639 A MX2010004639 A MX 2010004639A MX 2010004639 A MX2010004639 A MX 2010004639A MX 2010004639 A MX2010004639 A MX 2010004639A
Authority
MX
Mexico
Prior art keywords
liquid formulations
relates
pharmaceutical formulations
liquid pharmaceutical
luteinizing hormone
Prior art date
Application number
MX2010004639A
Other languages
English (en)
Inventor
Rita Agostinetto
Fabrizio Samaritani
Alessandra Del Rio
Joel Richard
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of MX2010004639A publication Critical patent/MX2010004639A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a formulaciones farmacéuticas líquidas de hormona luteinizante (LH) para administración en una sola dosis o en múltiples dosis.
MX2010004639A 2007-11-01 2008-10-29 Formulaciones liquidas de hormona luteinizante (lh). MX2010004639A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07119832 2007-11-01
US448107P 2007-11-28 2007-11-28
PCT/EP2008/064679 WO2009056569A1 (en) 2007-11-01 2008-10-29 Lh liquid formulations

Publications (1)

Publication Number Publication Date
MX2010004639A true MX2010004639A (es) 2010-08-04

Family

ID=39167502

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004639A MX2010004639A (es) 2007-11-01 2008-10-29 Formulaciones liquidas de hormona luteinizante (lh).

Country Status (26)

Country Link
US (1) US8664369B2 (es)
EP (1) EP2219607B1 (es)
JP (1) JP5551601B2 (es)
KR (1) KR101513181B1 (es)
CN (1) CN101842083B (es)
AU (1) AU2008320844B2 (es)
BR (1) BRPI0818324B8 (es)
CA (1) CA2700662C (es)
CY (1) CY1113121T1 (es)
DK (1) DK2219607T3 (es)
EA (1) EA019432B1 (es)
EC (1) ECSP10010224A (es)
ES (1) ES2393233T3 (es)
HK (1) HK1145443A1 (es)
HR (1) HRP20120660T1 (es)
IL (1) IL205105A (es)
MX (1) MX2010004639A (es)
MY (1) MY153976A (es)
NZ (1) NZ583991A (es)
PL (1) PL2219607T3 (es)
PT (1) PT2219607E (es)
RS (1) RS52566B (es)
SI (1) SI2219607T1 (es)
UA (1) UA101484C2 (es)
WO (1) WO2009056569A1 (es)
ZA (1) ZA201001907B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
MX344293B (es) 2008-10-17 2016-12-13 Sanofi Aventis Deutschland Combinacion de una insulina y un agonista de glp-1.
JP2011001273A (ja) * 2009-06-16 2011-01-06 Eci Inc ｅＭＩＰを有効成分とする水溶性製剤
PT2451437T (pt) * 2009-07-06 2017-01-17 Sanofi Aventis Deutschland Preparações aquosas de insulina contendo metionina
KR101772372B1 (ko) * 2009-11-13 2017-08-29 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
AU2010317995B2 (en) 2009-11-13 2014-04-17 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
RU2553375C2 (ru) * 2010-02-12 2015-06-10 Интас Биофармасьютикалс Лимитед Жидкий состав фолликулостимулирующего гормона
CN103179978A (zh) 2010-08-30 2013-06-26 赛诺菲-安万特德国有限公司 Ave0010用于制造供治疗2型糖尿病用的药物的用途
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN102293756A (zh) * 2011-08-24 2011-12-28 蚌埠丰原涂山制药有限公司 一种尿促性素冻干粉针剂及其制备方法
AU2012300978B2 (en) 2011-08-29 2017-04-27 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CA2889162A1 (en) * 2012-12-26 2014-07-03 Wockhardt Limited Pharmaceutical composition
TWI641381B (zh) 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
AU2015205624A1 (en) 2014-01-09 2016-07-14 Sanofi Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
CA2932875A1 (en) 2014-01-09 2015-07-16 Sanofi Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
MX2016008977A (es) 2014-01-09 2016-10-04 Sanofi Sa Formulaciones farmaceuticas de insulina aspart estabilizadas.
TN2017000235A1 (en) 2014-12-12 2018-10-19 Sanofi Aventis Deutschland Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
GB201603280D0 (en) * 2016-02-24 2016-04-13 Ferring Bv Stable liquid gonadotropin formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5681302A (en) * 1994-06-14 1997-10-28 Minnesota Mining And Manufacturing Company Elastic sheet-like composite
JP4165718B2 (ja) * 1995-03-21 2008-10-15 ラボラトワール セローノ ソシエテ アノニム ｈＣＧ液体製剤
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
JP4719357B2 (ja) * 1998-07-23 2011-07-06 アレス トレイディング ソシエテ アノニム Ｆｓｈ及びｆｓｈ変異体の製剤、製品及び方法
DE602004019761D1 (de) * 2003-01-08 2009-04-16 Novartis Vaccines & Diagnostic Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante
US7387998B2 (en) 2003-03-28 2008-06-17 New York University STQ peptides
RS57872B1 (sr) * 2003-04-02 2018-12-31 Ares Trading Sa Tečne farmaceutske formulacije fsh i lh zajedno sa nejonskim surfaktantom

Also Published As

Publication number Publication date
UA101484C2 (en) 2013-04-10
CN101842083B (zh) 2012-11-14
HK1145443A1 (en) 2011-04-21
RS52566B (en) 2013-04-30
HRP20120660T1 (hr) 2012-09-30
US20100261649A1 (en) 2010-10-14
ECSP10010224A (es) 2010-07-30
PL2219607T3 (pl) 2012-12-31
BRPI0818324B1 (pt) 2019-12-24
US8664369B2 (en) 2014-03-04
NZ583991A (en) 2012-02-24
EA019432B1 (ru) 2014-03-31
IL205105A (en) 2015-04-30
KR20100088147A (ko) 2010-08-06
CY1113121T1 (el) 2016-04-13
AU2008320844B2 (en) 2013-08-29
EP2219607A1 (en) 2010-08-25
AU2008320844A1 (en) 2009-05-07
CA2700662C (en) 2015-10-13
BRPI0818324B8 (pt) 2021-05-25
PT2219607E (pt) 2012-08-31
MY153976A (en) 2015-04-30
BRPI0818324A2 (pt) 2017-05-16
CN101842083A (zh) 2010-09-22
SI2219607T1 (sl) 2012-09-28
IL205105A0 (en) 2010-11-30
KR101513181B1 (ko) 2015-04-21
EP2219607B1 (en) 2012-08-15
ZA201001907B (en) 2011-05-25
ES2393233T3 (es) 2012-12-19
DK2219607T3 (da) 2013-06-17
JP2011502968A (ja) 2011-01-27
WO2009056569A1 (en) 2009-05-07
CA2700662A1 (en) 2009-05-07
WO2009056569A9 (en) 2010-01-21
JP5551601B2 (ja) 2014-07-16
EA201070549A1 (ru) 2010-10-29

Similar Documents

Publication Publication Date Title
MY153976A (en) Lh liquid formulations
JOP20200039A1 (ar) مُستحضر صيدلي يشتمل على hcg مأشوب
HK1164059A1 (en) Compositions for drug administration
MX336741B (es) Composiciones farmaceuticas de moduladores de c-met.
WO2013188792A3 (en) Neuroactive steroids, compositions, and uses thereof
EA031157B9 (ru) Вводимая перорально кортикостероидная композиция
CL2008000690A1 (es) Compuestos derivados del acido indol-3-propionico; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hiperlipidemia, hipertension; entre otras.
NZ608116A (en) Triazine-oxadiazoles
EP2419138A4 (en) GEL COMPOSITIONS FOR THE ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS
WO2011062437A3 (ko) 고나도트로핀 방출 호르몬 수용체 길항제, 이의 제조방법 및 이를 함유하는 약제학적 조성물
WO2011141685A3 (fr) Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants
IN2012DN02139A (es)
DK2482881T3 (da) Mekanisme til indretning til indlevering af lægemiddel
BR112015030387A2 (pt) compostos de pirazol como moduladores de fshr e usos dos mesmos
TN2009000510A1 (en) Extended release formulation of nevirapine
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
WO2007103867A3 (en) Tablet formulations and processes
ZA200807348B (en) Dosage aerosols for the administration of pharmaceutical preparations
WO2008034909A3 (en) Second line treatment of metastatic hormone refractory prostate cancer using satraplatin
PT2114367E (pt) Formulações de olopatadina para administração nasal tópica
AU2009298305A8 (en) Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormone (GnRH) as immunogen
MX2012015102A (es) Agentes terapeuticos 976.
MX2009002985A (es) Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (tsh).
EA201170843A1 (ru) Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью
PL2253326T3 (pl) Kompozycja farmaceutyczna do podawania przeznosowego

Legal Events

Date Code Title Description
FG Grant or registration